TOMAC: Bioinspired Flow Generation in Tubeless Organ-on-a-chip using Magnetic Artificial Cilia
The TOMAC project develops a Magnetic Artificial Cilia pump for Organ-on-a-Chip systems, enabling automated, physiological fluid flow to improve drug testing accuracy and industry adoption.
Projectdetails
Introduction
Currently, 90% of the drugs fail to pass clinical trials. One of the key reasons is that the animal models used in the preclinical phase poorly predict the human response to the drugs. Organ-on-a-Chip (OoC) is a game-changing technology as one of the alternative methodologies to animal models.
Organ-on-a-Chip Technology
The heart of an OoC system is an ‘Organ-chip’: cm-sized devices with micro-channels and chambers in which human cells can be grown to closely mimic human tissues. More and more evidence shows that OoCs are more representative models than animals.
Industry Adoption Challenges
However, the industry adoption of OoCs is still very limited. OoC users and developers simply have to choose between:
- OoCs with physiologically relevant flow but not fit for standard operating procedures in the pharmaceutical industry.
- OoCs that are compatible but less physiological because of the absence or inadequacy of the flow.
TOMAC Project Solution
The TOMAC project offers a novel solution called “Magnetic Artificial Cilia (MAC) pump”: a chip-sized modular and tubeless flow system that, on one hand, eliminates manual handling and enables automation, and on the other hand provides physiological flow for a range of organ models.
Technology Behind MAC
The technology behind MAC is based on micrometer-sized magnetic hair-like structures called Magnetic Artificial Cilia (MAC), which are inspired by cilia occurring in nature. The MAC are flexible micro-actuators that respond to a varying magnetic field (created by the actuation system) by rotating or oscillating, and thus create a controlled fluid flow.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-4-2024 |
Einddatum | 30-9-2025 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- TECHNISCHE UNIVERSITEIT EINDHOVENpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MANUNKIND: Determinants and Dynamics of Collaborative ExploitationThis project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery. | ERC STG | € 1.497.749 | 2022 | Details |
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressureThe UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance. | ERC STG | € 1.498.280 | 2022 | Details |
The Ethics of Loneliness and SociabilityThis project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field. | ERC STG | € 1.025.860 | 2023 | Details |
Uncovering the mechanisms of action of an antiviral bacteriumThis project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function. | ERC STG | € 1.500.000 | 2023 | Details |
MANUNKIND: Determinants and Dynamics of Collaborative Exploitation
This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure
The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.
The Ethics of Loneliness and Sociability
This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.
Uncovering the mechanisms of action of an antiviral bacterium
This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Evolving Organs-on-Chip from developmental engineering to “mechanical re-evolution”EvOoC develops smart Organs-on-Chip platforms that utilize mechanical forces and machine learning to enhance tissue regeneration and disease modeling for innovative therapeutic solutions. | ERC STG | € 2.430.625 | 2023 | Details |
PRECISIONDit project onderzoekt het gebruik van 3D-printing om de beperkingen van fotolithografie bij de productie van organ-on-chip modellen te overwinnen voor geneesmiddelentests en biologieonderzoek. | MIT Haalbaarheid | € 20.000 | 2022 | Details |
multisampLOC systeemCelnext en IMcoMET ontwikkelen een toegankelijk multisampLOC-systeem voor farmacologisch en biomedisch onderzoek, gericht op het verbeteren van de bemonsteling en throughput van 3D lever-modellen. | MIT Haalbaarheid | € 20.000 | 2022 | Details |
AdDitive mAnufacturing Microfluidica – ADAMPimBio B.V. ontwikkelt kosteneffectieve, klantspecifieke microfluïdische chips voor biotechnologie en gezondheidszorg om onderzoek te versnellen. | MIT Haalbaarheid | € 20.000 | 2020 | Details |
Evolving Organs-on-Chip from developmental engineering to “mechanical re-evolution”
EvOoC develops smart Organs-on-Chip platforms that utilize mechanical forces and machine learning to enhance tissue regeneration and disease modeling for innovative therapeutic solutions.
PRECISION
Dit project onderzoekt het gebruik van 3D-printing om de beperkingen van fotolithografie bij de productie van organ-on-chip modellen te overwinnen voor geneesmiddelentests en biologieonderzoek.
multisampLOC systeem
Celnext en IMcoMET ontwikkelen een toegankelijk multisampLOC-systeem voor farmacologisch en biomedisch onderzoek, gericht op het verbeteren van de bemonsteling en throughput van 3D lever-modellen.
AdDitive mAnufacturing Microfluidica – ADAM
PimBio B.V. ontwikkelt kosteneffectieve, klantspecifieke microfluïdische chips voor biotechnologie en gezondheidszorg om onderzoek te versnellen.